Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 29.55M | $ 4.32M | 14.61% |
3/31/2025 | $ 27.5M | $ 2.78M | 10.1% |
12/31/2024 | $ 26.73M | $ 2.17M | 8.14% |
9/30/2024 | $ 29.32M | $ 2.94M | 10.02% |
6/30/2024 | $ 28.23M | $ 2.88M | 10.21% |
3/31/2024 | $ 28.57M | $ 2.48M | 8.67% |
12/31/2023 | $ 27.86M | $ 2.13M | 7.63% |
9/30/2023 | $ 31.49M | $ 6.1M | 19.36% |
6/30/2023 | $ 28.44M | $ 1.42M | 5.01% |
3/31/2023 | $ 32.87M | $ 6.19M | 18.83% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: CashnEq [ $ 9.25M ] / Assets [ $ 27.21M ]
(=) Cash to Assets [ 33.99% ]
Minimum
Jun 30, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |